CIK 0001314102 · Non-accelerated filer<br>Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262774444
- Phone
- 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $52,258
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$52,258. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-09 | Lurker Nancy Executive Vice Chair | Option exercise | +17,534 | 172,975 | ||
| 2024-02-09 | Lurker Nancy Executive Vice Chair | Shares withheld for taxes | −7,962 | $28.80 | $229K | 165,013 |
| 2024-02-09 | Lurker Nancy Executive Vice Chair | Shares withheld for taxes | −6,981 | $28.80 | $201K | 158,032 |
| 2024-02-09 | Lurker Nancy Executive Vice Chair | Option exercise · Restricted Stock Units | −17,534 | 0 | ||
| 2024-02-09 | Lurker Nancy Executive Vice Chair | Option exercise · Restricted Stock Units | −20,000 | 20,000 | ||
| 2024-02-09 | Paggiarino Dario A. Chief Medical Officer | Option exercise | +4,967 | 41,472 | ||
| 2024-02-09 | Paggiarino Dario A. Chief Medical Officer | Option exercise | +5,833 | 47,305 | ||
| 2024-02-09 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −2,518 | $28.80 | $73K | 44,787 |
| 2024-02-09 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −2,565 | $28.80 | $74K | 42,222 |
| 2024-02-09 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Restricted Stock Units | −4,967 | 0 | ||
| 2024-02-09 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Restricted Stock Units | −5,833 | 5,834 | ||
| 2024-02-09 | Jones David Scott SVP & Chief Commercial Officer | Option exercise | +4,967 | 43,572 | ||
| 2024-02-09 | Jones David Scott SVP & Chief Commercial Officer | Option exercise | +5,000 | 48,572 | ||
| 2024-02-09 | Jones David Scott SVP & Chief Commercial Officer | Shares withheld for taxes | −1,955 | $28.80 | $56K | 46,617 |
| 2024-02-09 | Jones David Scott SVP & Chief Commercial Officer | Shares withheld for taxes | −1,701 | $28.80 | $49K | 44,916 |
| 2024-02-09 | Jones David Scott SVP & Chief Commercial Officer | Option exercise · Restricted Stock Units | −4,967 | 0 | ||
| 2024-02-09 | Jones David Scott SVP & Chief Commercial Officer | Option exercise · Restricted Stock Units | −5,000 | 5,000 | ||
| 2024-02-09 | Elston George Chief Financial Officer | Option exercise | +4,967 | 40,966 | ||
| 2024-02-09 | Elston George Chief Financial Officer | Option exercise | +5,833 | 46,799 | ||
| 2024-02-09 | Elston George Chief Financial Officer | Shares withheld for taxes | −1,734 | $28.80 | $50K | 45,065 |
Page 12 of 18 · 352 trades